Arlington Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,841
Closed -$231K 112
2025
Q4
$231K Hold
1,841
0.14% 95
2025
Q3
$247K Hold
1,841
0.16% 83
2025
Q2
$250K Hold
1,841
0.22% 71
2025
Q1
$244K Hold
1,841
0.19% 66
2024
Q4
$208K Hold
1,841
0.14% 84
2024
Q3
$210K Buy
+1,841
New +$202K 0.17% 79
2022
Q2
Sell
-2,172
Closed -$257K 4
2022
Q1
$257K Sell
2,172
-5
-0.2% -$620 1.04% 30
2021
Q4
$306K Buy
+2,177
New +$279K 0.55% 55
2021
Q3
Sell
-2,177
Closed -$252K 54
2021
Q2
$252K Hold
2,177
0.51% 47
2021
Q1
$261K Sell
2,177
-618
-22% -$73.2K 0.48% 43
2020
Q4
$306K Buy
+2,795
New +$304K 0.42% 53

Other funds holding ABT

Arlington Capital Management's ABT Position: Q1 2026 in Review

Arlington Capital Management sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,841 shares — an estimated $231K sold.

Arlington Capital Management first reported a position in ABT in Q4 2020 and held it in 11 quarters. The position peaked at $306K in Q4 2021. 3,091 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Arlington Capital Management reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Arlington Capital Management sold 1,841 Abbott shares in Q1 2026, an estimated $231K.
  • Arlington Capital Management first reported a position in Abbott in Q4 2020 and held it in 11 quarters.
  • Arlington Capital Management's Abbott position peaked at $306K in Q4 2021.
  • 3,091 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Arlington Capital Management's 13F filing for Q1 2026, filed 1 May 2026.